iMD Companies Expands Riize Product Line with New Offerings
![iMD Companies Expands Riize Product Line with New Offerings](https://investorshangout.com/images/blog/ihnews-iMD%20Companies%20Expands%20Riize%20Product%20Line%20with%20New%20Offerings.jpg)
iMD Companies, Inc. Expands Riize's Product Line
New Products Include High Demand Hair Loss, Weight Loss, and Woman's Libido Products
iMD Companies, Inc. (OTC: ICBU) has successfully acquired Riize, LLC (Riize). As a dynamic entity in telemedicine, Riize is set to diversify its product offerings and reshape its market presence, promising valuable growth prospects for both companies.
Riize has quickly emerged as a leader in the landscape of online personal healthcare, catering to both men and women. Over the span of less than a year, from September 2023 to March 2024, it reported impressive growth with a sixfold increase in sales order volume and tripling its subscriber base for sexual health products.
Exciting New Product Launches
As part of its expansion, Riize plans to introduce a range of products targeting Testosterone Replacement Therapy (TRT), Hormone Replacement Therapy (HRT), and solutions for Hair Growth, which are expected to roll out around mid-September 2024. The new offerings will focus on personal care areas projected to see growth rates exceeding 8%.
Telemedicine Platform Expansion
Furthermore, Riize is preparing to launch a telemedicine platform in Canada, integrating both pharmaceutical and healthcare provider options for all products, including those related to sexual wellness. This strategic move is scheduled for late September to early October 2024.
Leadership Insights
Reilly Schueler, CEO of Riize Health, commented, "Having proven the scalability of our business model and telemedicine platform with innovative sexual health products, joining with iMD brings a whole new set of strategic opportunities. As a wholly-owned subsidiary, we look forward to expanding our market reach and product lines."
Strengthening Market Position
The combined capabilities of Riize Health and iMD Companies are set to forge a more formidable presence in the telemedicine and personal healthcare sectors.
Rick Wilson, President and CEO of iMD Companies, expressed enthusiasm about the acquisition's completion, stating, “We’re eager to grow our subsidiary Riize. Stay tuned for upcoming announcements regarding product line expansions and revenue forecasts.”
About Riize, LLC
Riize is at the forefront of revolutionizing healthcare, recognized as a premier telemedicine and pharmacy service provider. With a cornerstone focus on sexual health and weight loss, Riize distinguishes itself by offering a convenient, online platform that connects patients with licensed medical professionals. This innovative approach prioritizes personalized care, enabling consultations via video or phone, facilitating accurate diagnoses, and developing tailored treatment plans to address individual needs.
Commitment to Access
Riize is dedicated to removing barriers to healthcare accessibility. Patients benefit from avoiding lengthy wait times and the need to travel to physical clinics. With just a few clicks, quality healthcare is accessible online, making patient health and well-being the primary concern.
About iMD Companies, Inc.
iMD Companies, Inc. (OTC: ICBU) is a Florida Corporation reimagined as a holding company for strategic acquisitions and technology advancements in healthcare. The vision behind iMD is to harmonize the skills and expertise of its team, establishing a unified front to propel the company towards success in the health market.
Contact Information
For further inquiries, contact:
iMD Companies, Inc.
info@imdcompaniesinc.com
Frequently Asked Questions
What is the main focus of the new products from Riize?
The new products from Riize will focus on hair loss, weight loss, and women's libido, expanding their healthcare product line significantly.
When will Riize's new products be available?
Riize plans to launch its new products around mid-September 2024.
Where will Riize expand its telemedicine services?
Riize is set to launch its telemedicine platform in Canada, offering a range of healthcare and pharmaceutical solutions.
Who is the CEO of Riize Health?
The CEO of Riize Health is Reilly Schueler, who is enthusiastic about the potential growth following the acquisition by iMD.
What is the main mission of iMD Companies, Inc.?
iMD Companies aims to unify expertise in healthcare to push forward as a cohesive entity in the market through acquisitions and innovation.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Felo AI Launch: Transforming Search with Language Innovation
- Earn Alliance Appoints Jeff Drobick as New COO to Enhance Growth
- Court TV Announces Exciting Fall Primetime Lineup for 2024
- Vishay Intertechnology Expands Haptic Feedback Actuators Range
- J.P. Morgan Enhances Morgan Money with Kyriba Integration
- Trump Hotels Enhances Operations with BirchStreet's ReactorNet
- Explore Local Wines with KSL Resorts' Exciting Package
- Accorto Regulatory Solutions Partners with GINN for Tobacco Safety
- Carterra Ultra™: Transforming Drug Discovery with Precision
- Autograph Revolutionizes Sports Fandom with New Platform
- Cape Electrical Supply Expands Services with Power Supply Acquisition
- Philadelphia Fed Initiates Search for New President Following Harker
- Israel Stock Exchange Overview: TA 35 Declines Amid Sectors
- Understanding Retirement with $600,000: Ways to Plan Ahead
- Introducing ISU Steadfast: A New Era in Insurance Networks
- Centene's Iowa Total Care Awarded New Medicaid Contract
- BIDFTA.COM Expands Auction Services with Bargain Hunt Deal
- New Jersey Takes a Stand: Knock Out Opioid Abuse Day Approaches
- Microban International Partners with CiCLO for Sustainable Textiles
- Middie Rising: A New Narrative for Schools in Transition
- Norfolk Southern Secures Tentative Agreement with Conductors' Union
- 3M Achieves Major Milestone with 300 Million Friction Shims
- Kontakt.io Revolutionizes Asset Tracking with Sticker Tag
- Jack Russell's Brush With Death After Skunk Encounter
- WellSync Enhances Healthcare with The Vitamin Shoppe Partnership
Recent Articles
- Endeavour Mining Updates on Major Shareholder Notification
- Mediaspace.global Launches Changemakers' Summit for 2024
- Exploring the Impact of the 2016 Election Docuseries
- Data Annotation Market to Hit USD 29.6 Billion by 2033
- Centene's Iowa Total Care Awarded New Medicaid Contract
- Integra LifeSciences Prepares for 2024 Wells Fargo Event
- Military Influencer Conference Set to Launch in Atlanta
- Jack Russell's Brush With Death After Skunk Encounter
- Empowerment Through Change: The New Knew's Gray Hair Course
- Acer Introduces Eco-Friendly Vero PD2 Series LED Projectors
- Sumeet Chabria Joins Genesis as Senior Advisor for Growth
- Innovations Fueling Growth in the Sustainable Label Market
- Keywords Studios Plc: Insight into Recent Disclosures
- Class Action Settlement for Packaged Tuna Purchasers Explained
- PennantPark Floating Rate Capital Ltd. Declares Monthly Dividend
- COVID-19 Therapeutics Market Expected to Surpass $16 Billion
- AB International Group Launches Film Subsidiary in China
- Michelin Reports Voting Rights and Share Capital Update
- MacPaw's CleanMy®Phone Triumphs with Double Design Awards
- Canaan Inc. Plans Participation in Annual Crypto Conference
- What If Media Group Fosters Innovation at LeadsCon Summit
- Brandon XIV's Groundbreaking Spoken Word Poetry Album: One Year
- Osisko Gold Royalties Offers Insightful Asset Updates
- Capsida Biotherapeutics to Showcase Advancements in Gene Therapy
- J.Jill Reports Strong Q2 Earnings but Cautious on Q3 Outlook